- Follicular lymphoma is a slow-growing subtype of non-Hodgkin lymphoma — five-year survival exceeds 80%.
- Up to 30% of people may never need treatment; "watch and wait" is often recommended when symptom-free.
- It can transform into a more aggressive form such as diffuse large B-cell lymphoma.
- It can be controlled for many years, but continuous immune-system support matters.
Lymphoma is a cancer of lymphocytes, a type of white blood cell. Lymphocytes circulate within the lymphatic system, which consists of the bone marrow, spleen, thymus and lymph nodes. Non-Hodgkin lymphoma is the most common type of lymphoma — and follicular lymphoma is one of its subtypes. Unlike some other types, follicular lymphoma usually grows slowly, so treatment may not be needed for many years. Up to 30% of people may never need treatment at all. The five-year survival rate for follicular lymphoma exceeds 80%.
Is follicular lymphoma inherited?
Although follicular lymphoma is not a hereditary disease, 5–10% of relatives of people with follicular lymphoma may also develop lymphoma. This is thought to be a consequence of lifestyle, other illnesses, or environmental factors.
Symptoms
The initial symptoms of follicular lymphoma are painless swelling of one or several lymph nodes, especially in the neck, armpits or groin. People with follicular lymphoma often report that their lymph nodes have been swollen for a long time. Some people develop large tumours in the abdomen, which may cause no symptoms but can block normal movement in the digestive or urinary systems or in blood vessels. Treatment may become necessary because of symptoms such as fever, night sweats, weight loss, pain, or organ obstruction. Some cases of follicular lymphoma can transform into a more aggressive form, such as diffuse large B-cell lymphoma, which grows faster and requires more intensive treatment.
Follicular lymphoma — treatment
Treatment depends on symptoms, tumour aggressiveness, age and general health. In most people with follicular lymphoma, the disease is already widespread at diagnosis. Because follicular lymphoma grows slowly, the disease may progress over many years during which treatment may not be needed — early treatment does not always improve overall survival if a person has no symptoms and the disease does not affect their organs, so "watch and wait" is often recommended.
Stage 1: some people with stage 1 disease can be treated with radiotherapy alone, achieving long-term remission in about half of cases. Radiotherapy uses high-energy rays to slow or stop the growth of cancer cells, directed at the affected lymph-node area, and is given in small daily doses over several weeks to reduce side effects. Stages 2–4: there are more treatment options; people are usually first treated with chemotherapy and anti-CD20 antibodies. If the lymphoma shrinks, maintenance antibody therapy may follow — this reduces lymphoma progression but does not improve survival.
Prognosis
As noted, long-term remission can be achieved with radiotherapy in stage 1 disease. For people with stage 2, 3 or 4, median survival is longer than 20 years. Despite the slow growth of this disease, it is unclear whether most cases of follicular lymphoma can be cured with currently available treatments. Follicular lymphoma can be controlled for many years, but the immune system must be continuously supported. Concentrated mushroom-polysaccharide formulas are studied for long-term immune-system support.
Follicular lymphoma can be controlled for years, but the immune system needs continuous support. Concentrated mushroom polysaccharides are studied for this role.
Lentinan AXT by Zenius Labs™ →The five-year survival rate for follicular lymphoma exceeds 80%. For people with stage 2, 3 or 4, median survival is longer than 20 years, as the disease grows slowly.
It is not a hereditary disease, but 5–10% of relatives of people with follicular lymphoma may also develop lymphoma — thought to be due to lifestyle, other illnesses or environmental factors.
No. Because it grows slowly, up to 30% of people may never need treatment. A "watch and wait" approach is often recommended when there are no symptoms and organs are unaffected, since early treatment does not always improve survival.
Yes. Follicular lymphoma can be controlled for many years, but the immune system must be continuously supported. Concentrated mushroom-polysaccharide formulas such as Lentinan AXT by Zenius Labs™ are studied for long-term immune support.